{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:48:03Z","timestamp":1791856083653,"version":"4.3.4"},"reference-count":27,"publisher":"Impact Journals, LLC","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,10,15]]},"DOI":"10.18632\/aging.204328","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:40:36Z","timestamp":1665416436000},"page":"7986-8000","source":"Crossref","is-referenced-by-count":7,"title":["High FHL2 mRNA expression and its prognostic value in lung cancer"],"prefix":"10.18632","volume":"14","author":[{"given":"Yan","family":"Jiao","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyuan","family":"Wei","sequence":"additional","affiliation":[{"name":"The Key Laboratory of Pathobiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.mcna.2018.12.006","article-title":"Lung Cancer.","volume":"10","author":"Eapen","year":"2019","journal-title":"Med Clin North Am"},{"key":"2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12885-018-4024-3","article-title":"Serum and blood based biomarkers for lung cancer screening: a systematic review.","volume":"1","author":"Sullivan","year":"2018","journal-title":"BMC Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/resp.13963","article-title":"Lung cancer screening implementation: Complexities and priorities.","volume":"2","author":"Marshall","year":"2020","journal-title":"Respirology"},{"key":"4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lungcan.2017.08.011","article-title":"Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review.","volume":"11","author":"Han","year":"2017","journal-title":"Lung Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.14670\/HH-11-709","article-title":"FHL2: a scaffold protein of carcinogenesis, tumour-stroma interactions and treatment response.","volume":"3","author":"Demetter","year":"2016","journal-title":"Histol Histopathol"},{"key":"6","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41388-017-0068-0","article-title":"FHL2 interacts with EGFR to promote glioblastoma growth.","volume":"3","author":"Li","year":"2018","journal-title":"Oncogene"},{"key":"7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1053\/j.gastro.2006.12.004","article-title":"Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.","volume":"13","author":"Wong","year":"2007","journal-title":"Gastroenterology"},{"key":"8","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1038\/onc.2016.54","article-title":"Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells.","volume":"3","author":"Bae","year":"2016","journal-title":"Oncogene"},{"key":"9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00018-005-5438-z","article-title":"The multifunctional roles of the four-and-a-half-LIM only protein FHL2.","volume":"6","author":"Van Ghelue","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1093\/nar\/gkp332","article-title":"FHL2 interacts with and acts as a functional repressor of Id2 in human neuroblastoma cells.","volume":"3","author":"Yu","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/leu.2014.254","article-title":"FHL2 regulates hematopoietic stem cell functions under stress conditions.","volume":"2","author":"Qian","year":"2015","journal-title":"Leukemia"},{"key":"12","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease.","volume":"14","author":"Nusse","year":"2012","journal-title":"Cell"},{"key":"13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer.","volume":"3","author":"Boutros","year":"2017","journal-title":"Oncogene"},{"key":"14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer.","volume":"1","author":"Moon","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"15","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"The Wnt\/\u03b2-catenin pathway in ovarian cancer: a review.","volume":"13","author":"Buchsbaum","year":"2013","journal-title":"Gynecol Oncol"},{"key":"16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature22334","article-title":"A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma.","volume":"54","author":"Cornwall-Brady","year":"2017","journal-title":"Nature"},{"key":"17","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1074\/jbc.M207216200","article-title":"Identification of the LIM protein FHL2 as a coactivator of beta-catenin.","volume":"27","author":"Buendia","year":"2003","journal-title":"J Biol Chem"},{"key":"18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1083\/jcb.200202075","article-title":"The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts.","volume":"15","author":"Wixler","year":"2002","journal-title":"J Cell Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"e55034","DOI":"10.1371\/journal.pone.0055034","article-title":"FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.","volume":"8","author":"Marie","year":"2013","journal-title":"PLoS One"},{"key":"20","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/carcin\/bgq094","article-title":"Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.","volume":"3","author":"Wong","year":"2010","journal-title":"Carcinogenesis"},{"key":"21","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/jcmm.13446","article-title":"FHL2 promotes tubular epithelial-to-mesenchymal transition through modulating \u03b2-catenin signalling.","volume":"2","author":"He","year":"2018","journal-title":"J Cell Mol Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jhep.2012.06.035","article-title":"The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.","volume":"5","author":"Nhieu","year":"2012","journal-title":"J Hepatol"},{"key":"23","first-page":"921","article-title":"Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer.","volume":"2","author":"M\u00fcller","year":"2004","journal-title":"Anticancer Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.actbio.2021.03.051","article-title":"Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma.","volume":"12","author":"Liu","year":"2021","journal-title":"Acta Biomater"},{"key":"25","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1021\/acs.molpharmaceut.0c01225","article-title":"Combining Gemcitabine-Loaded Macrophage-like Nanoparticles and Erlotinib for Pancreatic Cancer Therapy.","volume":"1","author":"Liu","year":"2021","journal-title":"Mol Pharm"},{"key":"26","unstructured":"R Core Team. R: A language and environment for statistical computing. 2013."},{"key":"27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves.","volume":"1","author":"M\u00fcller","year":"2011","journal-title":"BMC Bioinformatics"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T01:08:22Z","timestamp":1666228102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":27,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2022,10,15]]}},"alternative-id":["204328","36227138"],"URL":"https:\/\/doi.org\/10.18632\/aging.204328","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}